Product Information

CLONAZEPAM 0.125 MG DIS TAB is a generic product labeled by Par Health USA, LLC, priced at $0.4934 per EA under NDC 49884030602. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Aug 3, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLONAZEPAM 0.125 MG DIS TAB

clonazepam
$0.4934per EA
DEA Schedule CIV

Strength

.125 mg/1

NDC

49884030602

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLONAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA077171

FDA Approved

8/3/2005

TE Code

AB

On Market Since

8/5/2005

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for CLONAZEPAM 0.125 MG DIS TAB has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 36.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4934 per EA
All-time high$0.8730 (Aug 12, 2015)
All-time low$0.4221 (Jul 17, 2024)
52-week high$0.6134
52-week low$0.4934
Median price$0.6614
Average price$0.6506
Largest weekly change+47.8% (Aug 21, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-1.1%

1M

-5.1%

3M

-5.8%

6M

-5.3%

1Y

-13.0%

3Y

-22.3%

5Y

-22.0%

All

-36.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clonazepam market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLONAZEPAM 0.125 MG DIS TAB?

The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.125 MG DIS TAB, manufactured by Par Health USA, LLC, is $0.4934 per EA (NDC 49884030602), effective Nov 18, 2026.

How has the price of CLONAZEPAM 0.125 MG DIS TAB changed over time?

Over the history we have for it, the NADAC for CLONAZEPAM 0.125 MG DIS TAB has declined 36.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.125 MG DIS TAB?

Since Nov 28, 2013, the NADAC for CLONAZEPAM 0.125 MG DIS TAB has ranged from a low of $0.4221 (Jul 17, 2024) to a high of $0.8730 (Aug 12, 2015), with a median of $0.6614 per EA.

Are there cheaper alternatives to CLONAZEPAM 0.125 MG DIS TAB?

No other NADAC-published product currently shares the active ingredient and strength of CLONAZEPAM 0.125 MG DIS TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CLONAZEPAM 0.125 MG DIS TAB?

CLONAZEPAM 0.125 MG DIS TAB (NDC 49884030602) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.